|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5600 AUD | -2.61% |
|
-5.08% | +40.00% |
Company Valuation: Alterity Therapeutics Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 43.75 | 21.56 | 11.37 | 14 | 59.84 | 85.18 | - | - |
| Change | - | -50.72% | -47.27% | 23.14% | 327.48% | 42.34% | - | - |
| Enterprise Value (EV) 1 | 43.75 | 21.56 | 11.37 | 9.172 | 38.2 | 39.99 | 44.3 | 48.07 |
| Change | - | -50.72% | -47.27% | -19.31% | 316.5% | 4.68% | 10.77% | 8.53% |
| P/E | - | - | - | - | - | -0.33x | -0.33x | -0.33x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | - | - | - | - | - | -0.56x | -1.7x |
| Capitalization / Revenue | 13.3x | 6.11x | 4.45x | 4.81x | 11.3x | 33.2x | 71x | 35.7x |
| EV / Revenue | 13.3x | 6.11x | 4.45x | 3.15x | 7.24x | 15.6x | 36.9x | 20.2x |
| EV / EBITDA | - | - | - | -0.71x | -4.68x | -2.56x | -1.95x | -2.07x |
| EV / EBIT | -4.07x | -2.07x | -1.22x | -0.71x | -4.87x | -2.38x | -1.4x | -1.35x |
| EV / FCF | - | -2.53x | - | -1.07x | -5.11x | -3.83x | -2.04x | -2.25x |
| FCF Yield | - | -39.6% | - | -93.4% | -19.6% | -26.1% | -49.1% | -44.5% |
| Dividend per Share 3 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 3 | - | - | - | - | - | -1.707 | -1.717 | -1.72 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 3.292 | 3.528 | 2.554 | 2.909 | 5.278 | 2.568 | 1.2 | 2.383 |
| EBITDA 1 | - | - | - | -12.95 | -8.155 | -15.64 | -22.74 | -23.26 |
| EBIT 1 | -10.75 | -10.42 | -9.321 | -12.97 | -7.839 | -16.81 | -31.6 | -35.56 |
| Net income 1 | -11.19 | -8.843 | -8.966 | -12.97 | -7.927 | -14.64 | -29.66 | -33.25 |
| Net Debt 1 | - | - | - | -4.826 | -21.64 | -45.19 | -40.88 | -37.1 |
| Reference price 3 | 1.4000 | 0.6500 | 0.3500 | 0.2000 | 0.5000 | 0.5600 | 0.5600 | 0.5600 |
| Nbr of stocks (in thousands) | 41,680 | 48,137 | 48,798 | 104,902 | 182,547 | 217,508 | - | - |
| Announcement Date | 8/31/21 | 8/31/22 | 8/31/23 | 8/29/24 | 8/28/25 | - | - | - |
1AUD in Million2USD in Million3AUD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.33x | 15.57x | -2.56x | - | 85.18M | ||
| 32.24x | 5.76x | 17.3x | 1.02% | 46.86B | ||
| -23.62x | 354.58x | -21.66x | -.--% | 40.23B | ||
| 48.91x | 4.94x | 31.87x | -.--% | 36.23B | ||
| 25.32x | 2.8x | 12.1x | -.--% | 34.72B | ||
| 27.42x | 8.04x | 20.17x | 0.41% | 27.89B | ||
| 34.31x | 5.61x | 25.58x | -.--% | 16.79B | ||
| 22.5x | 1.95x | 8.49x | 1.18% | 13.12B | ||
| 23.43x | 1.87x | 11.34x | -.--% | 12.7B | ||
| Average | 21.13x | 44.57x | 11.40x | 0.33% | 25.4B | |
| Weighted average by Cap. | 22.51x | 66.40x | 12.08x | 0.33% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ATH Stock
- Valuation Alterity Therapeutics Limited
Select your edition
All financial news and data tailored to specific country editions
















